Search concepts
|
Selected Filters
|
Search results
-
ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib
John Manning, Cheng Huang & Slobodan Paessler
5/20/20
18 items of Media coverage
Press/Media: Expert Comment
-
'Concerning' COVID surge in use of Z-drugs, benzos - especially in women
10/26/21
1 item of Media coverage
Press/Media: Expert Comment
-
Family health; UTMB set to research breast milk's COVID-19 antibodies
Roberto P. Garofalo & George Saade
1/28/21
1 item of Media coverage
Press/Media: Expert Comment
-
ANTIBODY FINDING RAISES HOPES FOR MARBURG, COVID-19 TREATMENTS
4/30/20
1 item of Media coverage
Press/Media: Expert Comment
-
Advances In COVID-19 Testing, Artificial Intelligence, Cancer Therapies, And The Future Of Precision Medicine To Be Explored At The All-Virtual 2020 AACC Annual Scientific Meeting
12/13/20 → 12/14/20
3 items of Media coverage
Press/Media: Expert Comment
-
Taconic Biosciences to Distribute Critical COVID-19 Mouse Model
6/22/20 → 6/23/20
2 items of Media coverage
Press/Media: Expert Comment
-
La Marque man recovering after 51 days in the hospital fighting COVID-19
5/27/20
1 item of Media coverage
Press/Media: Expert Comment
-
Public statement for collaboration on COVID-19 vaccine development
Trevor Brasel, Chien-Te Tseng & Gary Kobinger
4/13/20 → 4/14/20
8 items of Media coverage
Press/Media: Expert Comment
-
ViralClear To Host Conference Call On June 9th To Discuss Upcoming And Recent Developments For Phase II Human Clinical Trials Of Its Broad-Spectrum Oral Anti-viral Candidate For Treatment Of COVID-19
John Manning, Cheng Huang & Slobodan Paessler
6/1/20
14 items of Media coverage
Press/Media: Expert Comment
-
FDA Clears the Investigational New Drug Application to Enable the Phase II Trial of ViralClear's Merimepodib, Oral Solution to Treat Adult Patients with Advanced COVID-19, to Proceed Nasdaq:BSGM
John Manning, Cheng Huang & Slobodan Paessler
5/18/20
13 items of Media coverage
Press/Media: Expert Comment
-
14:06 EDT Sorrento announces COVID-19 research testing agreement with UTMB
Cheng Huang & Slobodan Paessler
3/31/20
1 item of Media coverage
Press/Media: Expert Comment
-
Sorrento to test COVID-19 candidates in preclinic via new collaboration
Cheng Huang & Slobodan Paessler
4/6/20
1 item of Media coverage
Press/Media: Expert Comment
-
VACCINE SMARTS-VOLUNTEERS VITAL IN FINDING EFFECTIVE COVID-19 VACCINE
8/19/20 → 8/20/20
2 items of Media coverage
Press/Media: Expert Comment
-
With fewer elective surgeries and steep COVID-19 expenses, UTMB to cut 200 jobs
8/11/20
1 item of Media coverage
Press/Media: Expert Comment
-
Young people are leading the rise of COVID cases in Michigan. Here's what it means.
7/15/20
1 item of Media coverage
Press/Media: Expert Comment
-
ViralClear Partners With Catalent On Potential Treatment For COVID-19
John Manning, Cheng Huang & Slobodan Paessler
6/22/20 → 6/23/20
36 items of Media coverage
Press/Media: Expert Comment
-
Sorrento Therapeutics And ViralClear Enter Into Agreement To Explore Combination Antibody Plus Antiviral Therapy Against COVID-19
John Manning, Cheng Huang & Slobodan Paessler
9/30/20
19 items of Media coverage
Press/Media: Expert Comment
-
Local providers begin to offer COVID-19 antibody testing in Galveston County
5/26/20
1 item of Media coverage
Press/Media: Expert Comment
-
FORMER SMOKERS MOST LIKELY TO BE HOSPITALIZED, DIE FROM COVID-19, NEW UTMB STUDY FINDS
5/17/21
1 item of Media coverage
Press/Media: Expert Comment
-
‘Like Christmas morning’ as Houston hospitals give first COVID-19 vaccine shots
12/16/20
2 items of Media coverage
Press/Media: Expert Comment
-
Bay briefs: Free COVID tests at UHCL; Hospital achieves patient-quality ranking
10/27/21
1 item of Media coverage
Press/Media: Expert Comment
-
There's a frantic global race for a COVID vaccine, and Houston hopes to be an ultimate winner
9/11/20
3 items of Media coverage
Press/Media: Expert Comment
-
Rice University Researchers Receive Funding to Develop Covid-19 Sensor System
2/22/21
1 item of Media coverage
Press/Media: Expert Comment
-
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis; Financialnewsmedia.com News Commentary
John Manning, Cheng Huang & Slobodan Paessler
4/23/20
1 item of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies: ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib
John Manning, Cheng Huang & Slobodan Paessler
5/20/20
1 item of Media coverage
Press/Media: Expert Comment